| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |